| Neurological Disease Evaluation |
| ACHR ( Acetyl choline receptor Ab) |
| Aldolase |
| ANA |
| Anti aquaporin – 4 Antibody or Anti Aqp-4 (NMO-IgG ) |
| Anti –Cardiolopin IgG |
| Anti –Cardiolopin IgM |
| Anti- CCP ( Cyclic citrullinated protein ) |
| Anti- ds DNA |
| Anti- GAD II (Glutamic Acid Decarboxylase) |
| Anti –Musk (Muscle specific receptor tyrosin kinase) |
| Anti- Phospholipid IgG |
| Anti –Phospholipid IgM |
| Anti –SCL 70 |
| Anti- sn RNP |
| Anti- SSA ( RO ) |
| Anti- SSB ( LA ) |
| Anti- Thrombin III |
| B2 Glycoprotein Ab |
| C3 |
| C4 |
| CH50 |
| CIC ( Circulating immune complex ) |
| CPK |
| CRP ( Quantitative ) |
| CSF, Beta2 microglobulin |
| CSF Indian ink staining |
| CSF, Lactate |
| CSF Oligoclonal band, IgG Index |
| C – ANCA |
| P – ANCA |
| High sensitive CRP |
| HLA B5 |
| HLA B8 |
| HLA B27 |
| (IgG, IgM,IgA) , CSF |
| Lupus Anticoagulant |
| Osteocalcin |
| PTH |
| RA ( Rheumatoid Factor ), ( Quantitative ) |
| Vitamin D3, 25 OH |
| Protein C |
| Protein S |
| Vitamin B12 |
| Ceruloplasmin (Cp) & copper : neurodegenerative symptoms and signs of connective tissue disease in infants and small children (suspected Menkes disease) |